Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
MariBiz Garners Enthusiastic Response at California Cannabis Business
Expo for Its Unique, Innovative, Mobile-First Platform for Canna-Business
Owners
Startup mobile solutions
provider offers modular tools and effortless scalability to support a rapidly
growing industry.
LAS VEGAS - March 27, 2017 (Investorideas.com Newswire) MariBiz (http://maribiz.com/), the mobile-first
platform for canna-businesses that wants to turn #Green2Gold, made big noise at
the California Cannabis Business Expo in San Diego - and the investment
community is taking notice. The company offers first-of-its-kind software
designed exclusively for cannabis dispense-and-deliver services, which are
witnessing dramatic growth everywhere cannabis products have been approved.
"Our booth was packed all day long," says MariBiz
Principal and Founder Robert Keller, "because no one is doing what we're
doing. The industry is still in its infancy, and there is a lot of confusion
and disorganization facing canna-businesses, especially those not of the
brick-and-mortar variety. We solve those problems with smart, user-friendly
software and solid advice at a price that small business entrepreneurs will
appreciate."
MariBiz
at California Cannabis Business Expo, San Diego, March 7 2017
The legalization of recreational marijuana in California
represents a landmark moment for the entire industry, as the sheer size of the
state's economy translates into substantial inertia toward a rethinking of
policy at the national level. According to Time Magazine, the California market
for cannabis products could surpass $6 billion by 2020. And that market will
need a vast human and technical infrastructure to support it. MariBiz hopes to
fill that void: By streamlining the front- and back-office work of cannabis
dispense-and-deliver services, more businesses will be able to participate in
the market effectively and produce the kind of innovation today's consumers
expect. In short, all the pieces are in place for MariBiz to see strong,
sustainable growth for years to come.
Standard features of MariBiz include mobile and desktop versions
of a web store, point-of-sale system, a delivery system, CSS customization, and
robust data encryption. Other features are available as modular tools, so
canna-business owners can purchase exactly what they need at an affordable
price, then add more tools as their commerce expands.
"We leveraged decades worth of real-world experience in
canna-business to create the perfect mobile-first solution for this new and
complex market," adds Keller. "Moreover, our software development is
customer-driven, not programmer-driven. We are creating software and solutions
that conform to the needs of these unique businesses, instead of forcing the
business to conform to the software."
In the near term, MariBiz plans to open a round of Series A
funding while at the same time rolling out new service offerings. The company
is also looking at a rapid U.S. expansion as legalization efforts in other
states gather momentum.
About MariBiz
Launched in January 2017, MariBiz is a solutions company,
helping canna-businesses attract more customers, sell more product and make
more money with less work and expense. MariBiz is an affordable software
platform that streamlines complicated sales, delivery and inventory processes
into a simple interface, while protecting business owners and their
clients/patients/members with encryption. MariBiz was founded by a group with
decades of experience as entrepreneurs, industry insiders and technical
developers.
This news is published on
the Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure:Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding
BC Residents and global Investors: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info:http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
Medical
Marijuana Stock News: Canabo (TSX VENTURE: $CMM) (OTCQB: $CAMDF) Opens Clinic
in St. Catharine's, Ontario
ST. CATHARINE'S, ON - March 27, 2017
(Investorideas.com Newswire) Canabo Medical Inc. (TSX VENTURE: CMM) (OTCQB:
CAMDF) ("Canabo" or the "Company") is pleased to announce
it has opened a clinic in St. Catharine's, Ontario. Canabo clinics specialize
in assisting referred patients with a wide variety of chronic conditions
through medical marijuana treatments. Our St. Catharine's clinic is located at
180 Vine Street South.
Dr. Neil Smith, Executive Chairman of
Canabo Medical Inc. stated, "Our clinic in St. Catharine's is opening on
the heels of our clinic opening in Chilliwack. We are aggressively expanding
across Canada as more Physicians and patients alike want to be involved in
CMC."
Canabo wholly owns and operates 14
Cannabinoid Medical Clinics, or CMClinics, Canada's most respected and largest
referral-only clinics for medical cannabis. Since beginning operations in 2014,
Canabo now has clinic locations in Toronto, Barrie, St. Catharine's,
Burlington, Stoney Creek, Ottawa, Hamilton, Halifax, St. John's, Moncton,
Kingston, Edmonton, Calgary and Chilliwack. The company has plans to open an
additional 8 clinics in 2017.
Neither the TSX Venture Exchange nor
its Regulation Services Provider (as that term is defined in policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of
this news release.
Forward Looking Statements
Canabo
Except for historical information,
this press release contains forward-looking statements, which reflect Canabo
Medical Inc.'s current expectations regarding future events. These
forward-looking statements involve known and unknown risks and uncertainties
that could cause Canabo's actual results to differ materially from those
statements. Those risks and uncertainties include, but are not limited to, the
Company's ability to access capital, the successful and timely completion of
opening clinics, regulatory changes, competition, approvals and other business
and industry risks.
The forward-looking statements in
this press release are also based on a number of assumptions which may prove to
be incorrect. Forward-looking statements contained in this press release
represent views only as of the date of this release and are presented for the
purpose of assisting potential investors in understanding Canabo's business and
may not be appropriate for other purposes. Canabo does not undertake to update
forward-looking statements, whether written or oral, that may be made from time
to time by or on its behalf, except as required under applicable securities
legislation. Investors are cautioned not to rely on these forward-looking
statements and are encouraged to consult with a professional investment
advisor.
Readers are cautioned that the
foregoing list is not exhaustive. Readers are further cautioned not to place
undue reliance on forward-looking statements as there can be no assurance that
the plans, intentions or expectations upon which they are placed will occur.
Such information, although considered reasonable by management at the time of
preparation, may prove to be incorrect and actual results may differ materially
from those anticipated. Forward looking statements contained in this news
release are expressly qualified by this cautionary statement.
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
#Cannabis
Stock News: Nutritional High (CSE: $EAT) (CSE: EAT.CN) (OTCQB: $SPLIF)
Announces Closing of Oregon Property Acquisition and an Update on Licensing
TORONTO, ONTARIO - March 27, 2017
(Investorideas.com Newswire) Nutritional High International Inc. (the
"Company" or "Nutritional High")
(CSE:EAT)(CSE:EAT.CN)(OTCQB:SPLIF)(FRANKFURT:2NU) is pleased to announce that
is has closed an acquisition of a real estate property in The City of La Pine
located in Deschutes County, Oregon where the Company intends to extract
cannabis oil, and manufacture cannabis infused products. The Company is in the
advanced stages of an application process to manufacture cannabis concentrates
and edibles with Oregon Liquor Control Commission ("OLCC") in
relation to the property.
Jim Frazier, CEO of Nutritional High
commented - "We're excited to announce this key milestone in Nutritional
High's expansion strategy, establishing our presence in Pacific Northwest. In
our view, the State of Oregon has one of the most robust cannabis regulation
and we are excited to be a part of this growing market. The move to establish
operations from the ground-up and receive a Processor License is consistent
with our growth strategy to secure a national foothold by replicating the
Colorado model in other states that regulated cannabis for adult and medical
use."
Oregon Licensing
Update and Construction Timeline
Nutritional High has contracted to
purchase the property in late 2015, soon after the State of Oregon published
the licensing rules for cannabis companies and applied for land use
compatibility survey ("LUCS") with the City of La Pine, which was
granted in April 2016. The LUCS permits the Company to manufacture concentrate
and topical products at its location in La Pine.
Since then, the Company has been
working with state and local regulatory authorities to obtain the necessary
permits to receive the Recreational Processor License from Oregon Liquor
Control Commission ("OLCC").
The Company has also been working
with architect and engineering teams out of Bend, OR to finalize the design of
the facility and work with local authorities to apply for requisite local
permits to start re-modelling of the facility. Earlier this year the Company
has secured the architectural and mechanical building permits from Deschutes
County Community Development Department ("DCCDD") and expects to
secure electrical and plumbing permits, which will enable the Company to commence
remodelling of the facility. The Company expects to commence construction in
calendar Q2 of 2017. The construction is expected to take approximately three
to four months, and will be followed by the installation of equipment, which is
currently being ordered to minimize the lead time to commence production.
After completing the construction,
the facility will be inspected by Oregon Department of Agriculture
("DOA") and OLCC, upon successful completion of which the
Recreational Processing License from the State will be granted. The final steps
in the permitting process include the inspection by the DCCDD, and certain
departments of The City of La Pine, including the fire chief, planning
department and the City manager.
Licensed cannabis companies in the
State of Oregon are not subject to residency requirements. As such, the
licensed operator will be wholly owned by Nutritional High.
The Company acquired La Pine Property
for approximately US$404,925, which was paid for in cash. The Company may
consider obtaining secured financing against the property in future.
Oregon Business
Plan Update
Upon fully completing Phase I
construction and permitting, the Company will focus on rolling out its FLI
products in the State of Oregon. Nutritional High will emulate its Colorado
model, starting with bulk oil and cartridges, followed by edible and topical
products. The initial permitting and design was focused on replicating the
extraction process in Pueblo, CO, using ethanol-based primary extraction method
and short-path distillation to purify the oil.
Once the production of concentrate
products has commenced, the Company will begin planning and obtaining requisite
permits for Phase II (including an updated LUCS), which would be focused on
manufacturing cannabis-infused edible products. The La Pine facility has a
total square footage of approximately 5,000 square feet, which is sufficient to
house a robust extraction and infused product manufacturing operation and
manufacture more than a dozen of product lines.
Oregon Cannabis
Market
The State of Oregon has one of the
oldest medical cannabis programs in the Country, having passed Measure 67 in
1998, and in 2014 Oregon passed Ballot Measure 91, which has legalized cannabis
for adult use. According to OLCC data, retail sales of cannabis for the week of
01/22/2017 were slightly above $5 million1, which would represent an annualized
revenue of approximately $260 million, with approximately 30% of the market
representing non-flower marijuana products such as concentrates, topicals and
edibles. Total sales are expected to significantly accelerate, since most the
retail establishments are still being approved by the regulators.
According to ArcView Market Research
Data, Oregon is sixth in the nation in per capita marijuana use at 16.7%, which
pegs the market at approximately 660,000 consumers2. The market is projected to
grow to almost $1 billion in sales by 2020.
About Nutritional
High International Inc.
Nutritional High is focused on
developing, manufacturing and distributing products and nationally recognized
brands in the hemp and marijuana-infused products industries, including edibles
and oil extracts for nutritional, medical and adult recreational use. The
Company works exclusively through licensed facilities in jurisdictions where
such activity is permitted and regulated by state law.
For updates on the Company's
activities and highlights of the Company's press releases and other media
coverage, please follow Nutritional High on Facebook, Twitter, Instagram and
Google+ or visit www.nutritionalhigh.com.
NEITHER THE CANADIAN SECURITIES
EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS
HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS
RELEASE.
This news release may contain
forward-looking statements and information based on current expectations. These
statements should not be read as guarantees of future performance or results.
Such statements involve known and unknown risks, uncertainties and other
factors that may cause actual results, performance or achievements to be
materially different from those implied by such statements. Such statements
include submission of the relevant documentation within the required timeframe
and to the satisfaction of the relevant regulators, completing the acquisition
of the applicable real estate and raising sufficient financing to complete the
Company's business strategy. There is no certainty that any of these events will
occur. Although such statements are based on management's reasonable
assumptions, there can be no assurance that such assumptions will prove to be
correct. We assume no responsibility to update or revise them to reflect new
events or circumstances.
Company's securities have not been
registered under the U.S. Securities Act of 1933, as amended (the "U.S.
Securities Act"), or applicable state securities laws, and may not be
offered or sold to, or for the account or benefit of, persons in the United
States or "U.S. Persons", as such term is defined in Regulation S
under the U.S. Securities Act, absent registration or an applicable exemption
from such registration requirements. This press release shall not constitute an
offer to sell or the solicitation of an offer to buy nor shall there be any
sale of the securities in the United States or any jurisdiction in which such
offer, solicitation or sale would be unlawful.
Additionally, there are known and
unknown risk factors which could cause the Company's actual results,
performance or achievements to be materially different from any future results,
performance or achievements expressed or implied by the forward-looking
information contained herein. All forward-looking information herein is
qualified in its entirety by this cautionary statement, and the Company
disclaims any obligation to revise or update any such forward-looking
information or to publicly announce the result of any revisions to any of the
forward-looking information contained herein to reflect future results, events
or developments, except as required by law.
Contact Information
Nutritional High International Inc.
David Posner
Chairman of the Board
647-985-6727
dposner@nutritionalhigh.com
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
Cannabis
Stock News: Quadron (CSE: $QCC) Completes R&D for Its Automated Odor
Elimination System to Eradicate Cannabis Odor
VANCOUVER, BRITISH COLUMBIA - March
24, 2017 (Investorideas.com Newswire) Quadron Capital Corporation (the
"Company" or "Quadron") - (CSE:QCC) - is pleased to report
the completion of the research and development of its newly designed,
proprietary automated Odor Elimination System ("OES") designed
specifically for the industrial cannabis industry. The company believes it is
the first, and most efficient solution in the market to eliminate residual
odors that remain after being filtered by industry standard carbon filtration
systems.
The automated OES monitors volatile
organic compound ("VOC") odor levels in a production facility's
exhaust system, and automatically delivers measured levels of ONA odor
neutralizer to eliminate residue cannabis smell. Quadron will sell the
proprietary OES and generate recurring revenue from the sale of ONA to its
clients.
ONA is a world-known cannabis odor
suppressant, used by cannabis cultivators in Canada, the US, UK and Europe
since 1995. ONA is specifically formulated to neutralize cannabis odor, without
leaving residual fragrance in the air.
With the expansion of legalized
cannabis production worldwide, cannabis odor from production facilities is a
major issue facing many licensed growers and their communities. Municipalities
are implementing odor control regulations. Facilities that do not adhere to
such odor control regulations can be subject to fines, and be required to add
odor control technology to their ventilation and filtration equipment.
Rosy Mondin, CEO of Quadron states,
"By monitoring and throttling the precise dosages of ONA, we efficiently
eliminate odors without creating any overpowering chemical smells. We believe
we will see more and more regulatory controls for licensed growers in regard to
odor control, and therefore see this as a large-scale opportunity to be a
global leader in the industrial cannabis odor abatement market."
Developed by Cybernetic Control
Systems (a Quadron subsidiary), the OES is fully ETL/CSA approved.
About Quadron:
Quadron operates through its two
subsidiaries: Soma Labs Scientific Inc. ("Soma") and Greenmantle
Products Limited ("Greenmantle"), providing ancillary equipment,
products and services, designed and structured to address the complex needs and
requirements of cannabis industry participants in Canada and the US. Soma
provides research, services and production equipment to the biotech and
bioceutical industries, including cannabis extraction and processing equipment
that is being leased and/or sold to various industry participants.
Greenmantle's business involves the sale of ancillary cannabis products, such
as customized dispensing devices (i.e. vaporizer pens) and consumption type
products such as branded encapsulation products to authorized cannabis industry
participants.
On behalf of the Board of Directors
of QUADRON CAPITAL CORPORATION
Rosy Mondin, Director
Neither the CSE nor its Regulation
Services Provider (as that term is defined in the policies of the CSE) accepts
responsibility for the adequacy or accuracy of this release.
Statements included in this
announcement, including statements concerning our plans, intentions and
expectations, which are not historical in nature are intended to be, and are
hereby identified as "forward-looking statements". Forward-looking
statements may be identified by words including "anticipates",
"believes", "intends", "estimates", "expects"
and similar expressions. The Company cautions readers that forward-looking
statements, including without limitation those relating to the Company's future
operations and business prospects, are subject to certain risks and
uncertainties that could cause actual results to differ materially from those
indicated in the forward-looking statements. Contact Information
Quadron Capital Corporation
Rosy Mondin
Director
(604) 346-8118
rosy@quadroncapital.ca www.quadroncapital.ca
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
Shine Papers
partners with The Game on new innovative line of cannabis products, launch
'Pure Leaf,' a luxury broadleaf wrap
March 24, 2017 (Investorideas.com
Newswire) Shine Papers, inventors of the world's first 24 karat gold rolling
papers, announces its official partnership with hip-hop artist and cannabis
community ambassador, Jayceon Taylor pka The Game, to develop an exclusive line
of luxury cannabis products.
The partnership will join two
game-changing innovators in the cannabis industry, to develop products that
will fill a void in the luxury cannabis product category, elevating the
customer experience at every turn.
The debut product will be a premium
broadleaf wrap called 'Pure Leaf,' a handpicked, natural leaf pack. "Not
only are there very few options in the natural wrap category, but what's
available often leaves much to be desired in freshness, quality, taste and ease
of use. The quality in the current market-place just isn't there," says
Shine CEO Dave Brown. "We're setting the quality control bar higher than
ever, hand-selecting each leaf to give users the best taste and freshness ever
experienced every single time."
In looking for a partner to
complement the vision for a premium broadleaf option, The Game was the perfect
fit, as a like-minded, passionate and forward-thinking member of the cannabis
industry.
"The absolute most important
things to me in the cannabis industry are community and innovation, without
them we have nothing. Shine's brand exemplifies those values . We're both in
this business to help shape the future of our industry and community, and we
intend on doing that together through innovative design and a "best in class"
approach to manufacturing and customer support" says The Game on the
partnership.
'Pure Leaf' is the first product in a
full line of innovation products to roll out from the ongoing partnership
between Shine Papers and The Game. 'Pure Leaf' [$5.49 for pack of 3] will be
available on 4/20/2017 at authorized retailers and online at shinepapers.com.
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
Cannabis
Stock News: 22nd Century (NYSE MKT: $XXII) Produces Zero THC Industrial Hemp at
Anandia Labs
22nd Century announces further
medical marijuana and industrial hemp investments
CLARENCE, N.Y. - March 24, 2017
(Investorideas.com Newswire) 22nd Century Group, Inc. (NYSE MKT:XXII), a plant
biotechnology company that is focused on tobacco harm reduction and cannabis
research, announced today that the Company's research collaboration with
strategic partner Anandia Laboratories, Inc. in Vancouver, Canada, has resulted
in new industrial hemp plants that have zero tetrahydrocannabinol (THC), the
principal psychoactive constituent in cannabis.
Cannabis sativa (marijuana, hemp) has
been used for millennia as a source of fiber, food (oil and protein), medicine
and as a recreational psychoactive drug. Drug type cannabis (marijuana) that is
typically used for medical and recreational purposes contains high levels of
THC and is defined as a Schedule 1 narcotic by the Drug Enforcement Agency
(DEA). Accordingly, the presence of THC in industrial hemp is one of the
biggest challenges facing the industrial hemp industry. Hemp crops are tested
for THC levels; under U.S. federal law, crops containing above 0.3% THC are
required to be destroyed. Currently, farmers cannot obtain crop insurance to
protect against this risk. 22nd Century has developed a solution to this
problem by creating industrial hemp plants that contain zero THC.
In order to build on the Company's
success with its THC-free hemp, the Company's wholly-owned subsidiary,
Botanical Genetics LLC (www.botanicalgenetics.com),
has approved an additional investment of approximately $800,000 in further
cannabis research with Anandia Labs. The Company's new investment in Anandia
Labs will be product-oriented and will focus on developing a range of next
generation industrial hemp plants that contain optimized levels of important
cannabinoids such as CBD, CBC, and CBG.
22nd Century will provide these
proprietary hemp plants to the Company's university research partners for
optimization in various climates around the world. THC-free cannabis is an
ideal agricultural crop and an excellent source of medically important
cannabinoids; 22nd Century has the exclusive rights to commercialize the plants
arising from this collaborative project in the United States.
This successful cannabinoid research
at Anandia Labs is the result of one of many of the Company's research
activities relating to industrial hemp plants and to the extraction of
medically-important cannabinoids for medical research. In conducting research
in this field, Botanical Genetics operates its own laboratories in New York and
collaborates with third-party research universities, commercial laboratories,
and hemp/cannabis growers that possess all necessary licenses and permits to
conduct their activities.
"We are delighted that our
exciting research with Anandia Labs has created zero THC plants and altered
levels of cannabinoids suitable for both industrial hemp and medical
marijuana," explained Dr. Paul Rushton, 22nd Century's Vice President for
Plant Biotechnology. "We anticipate that our zero THC hemp plants will
form the basis of a new generation of industrial hemp and medical marijuana
varieties. These markets are projected to be multi-billion dollar markets in
the near term."
Jonathan Page, Ph.D., President and
CEO of Anandia Labs, stated, "We are pleased that our initial project with
22nd Century has been such a success. These exciting results will help create
hemp varieties that reduce the significant regulatory challenges around THC in
the U.S. and position 22nd Century to be at the forefront of the renaissance in
hemp production."
About Botanical
Genetics
Botanical Genetics is at the
forefront of cannabis biotechnology. In partnership with Anandia Labs, a
leading Canadian cannabis research company, and in collaboration with several
major universities and hemp/cannabis companies, Botanical Genetics is able to
legally conduct a full spectrum of cutting edge cannabis research. This
includes development of proprietary cannabis strains for novel, safe and
effective medical applications and production of very low THC industrial hemp
varieties that may be legally grown in the U.S. and around the world as an
agricultural crop and/or as a source for the extraction of cannabinoids for
medical research purposes by third-parties with the proper permits and
licenses. Visitwww.botanicalgenetics.comfor information about the Company's activities in the rapidly evolving
areas of legal industrial hemp and legal medical marijuana.
About 22nd Century
Group, Inc.
22nd Century is a plant biotechnology
company focused on technology which allows it to increase or decrease the level
of nicotine in tobacco plants and the level of cannabinoids in cannabis plants
through genetic engineering and plant breeding. The Company's primary mission
is to reduce the harm caused by smoking. 22nd Century currently owns or
exclusively controls more than 200 issued patents and more than 50 pending
patent applications around the world. Visitwww.xxiicentury.comfor more information.
About Anandia
Laboratories Inc.
Anandia Labs is a Health Canada
licensed company focused exclusively on cannabis breeding and testing, with the
aim of bringing the best of modern science to the cannabis industry for the
benefit of growers and consumers. Anandia Labs provides a full suite of
third-party independent cannabis testing services to clients within Canada's
legal medical cannabis industry. Visitwww.anandialabs.comfor more information.
Cautionary Note Regarding Forward-Looking
Statements: This press release contains forward-looking information, including
all statements that are not statements of historical fact regarding the intent,
belief or current expectations of 22nd Century Group, Inc., its directors or
its officers with respect to the contents of this press release, including but
not limited to our future revenue expectations. The words "may,"
"would," "will," "expect," "estimate,"
"anticipate," "believe," "intend" and similar
expressions and variations thereof are intended to identify forward-looking
statements. We cannot guarantee future results, levels of activity or
performance. You should not place undue reliance on these forward-looking
statements, which speak only as of the date that they were made. These cautionary
statements should be considered with any written or oral forward-looking
statements that we may issue in the future. Except as required by applicable
law, including the securities laws of the United States, we do not intend to
update any of the forward-looking statements to conform these statements to
reflect actual results, later events or circumstances, or to reflect the
occurrence of unanticipated events. You should carefully review and consider
the various disclosures made by us in our annual report on Form 10-K for the
fiscal year ended December 31, 2016, filed on March 8, 2017, including the
section entitled "Risk Factors," and our other reports filed with the
U.S Securities and Exchange Commission which attempt to advise interested
parties of the risks and factors that may affect our business, financial
condition, results of operation and cash flows. If one or more of these risks
or uncertainties materialize, or if the underlying assumptions prove incorrect,
our actual results may vary materially from those expected or projected.
Contacts
22nd Century Group
Investor Relations:
IRTH Communications
Andrew Haag, 866-976-4784
xxii@irthcommunications.com
Anandia Laboratories Inc.
Jonathan Page, 604-822-0253
President and CEO
jpage@anandialabs.com
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
